Cookies used for improved website experience

Siemens Healthineers and our partners use cookies and other similar technologies to operate the Siemens Healthineers websites and personalize content and ads. You may find out more about how we use cookies by clicking "Show details" or by referring to our Cookie Policy.
You may allow all cookies or select them individually. And you may change your consent and cookie preferences anytime by clicking on the "Review and change your consent" button on the Cookie Policy page.

The Cytokine Response to Sepsis: IL-6 and LBP

IL-6 and lipopolysaccharide binding protein (LBP) are cytokines (cellular messengers) that are upregulated in the acute phase response to infection and/or inflammation.


Interleukin 6 (IL-6) is a cytokine with both pro- and anti-inflammatory characteristics.

  • Serum levels rise quickly with the onset of SIRS and sepsis1
  • Levels can provide information for risk stratification and prognosis with regard to severity2,3
  • Rising levels correspond with increasing APACHE II scores (an in indicator of illness severity)4
  • Fatal severe sepsis is associated with an early rise in IL-6 to 1000 ng/mL or more4
  • High levels of IL-6 have shown to be predictive of later development of severe sepsis at the onset of hospital-acquired pneumonia and after surgery5,6
  • Rising levels can predict development of kidney injury during severe sepsis7

IL-6 may be of particular value in neonatology and pediatrics:

  • In healthy infants, adult levels are present at birth and remain stable
  • In infants at risk for late-onset neonatal sepsis, IL-6 has been shown to rise up to 48 hours before bacterial sepsis becomes clinically apparent8
  • Increased levels at hospital admission are predictive of septic shock in children9
  • Increased levels at hospital admission are predictive of septic shock and death in pediatric burn patients10

Lipopolysaccharide-binding protein (LBP) recognizes the endotoxin component of the gram-negative bacterial membranes. It also recognizes similar lipid structures found in the membrane of gram-positive bacteria and the walls of pathogenic fungi.11

  • LBP is present constitutively at low levels
  • LBP rises within 24 hours of systemic bacterial or fungal infection11,12
  • LBP can differentiate between bacterial and viral pathogenic sources of sepsis11,12
  • LBP can help differentiate between bacterial pneumonia and nonbacterial acute bronchitis13

LBP is a valuable tool in pediatrics

  • LBP rises in invasive bacterial infection in children14
  • Elevated LBP indicate bacterial infection in neonates ≥ 28 weeks gestation15
  • LBP may be the best differentiator between SIRS and early-onset sepsis in neonates <48 hrs old16

References
1. Woiciechowsky C, et al. J Trauma 2002; 52: 339-45.
2. Van Griensven M. Trauma und Infection. II Internationales Symposium: Sepsis, SIRS, Immunantwort. Diagnostik und Therapeutische Ansattze (Abstractband) 2002:24.
3. Wakefield CH, et al. Brit J Surg 1998; 85: 818-825.
4. Kinasewitz GT, et al. Crit Care 2004;8(2):R82.
5. Von Dossow V, et al. Crit Care 2005;9(6):R662.
6. Mokart D, et al. Brit J Anaes 2005;94:767-73.
7. Chawla LS, et al. Clin J Am Soc Nephrol 2007;2:22.
8. Küster H, et al. Lancet 1998;352:1271-77.
9. Fioretto JR, et al. Cytokine 2008; 43:160-164.
10. Finnerty CC, et al. Shock 2007; 27:4-9.
11. Blairon L, et al. J Infect Dis 2003;187:287-91.
12. Kaden J, et al. Transplantationsmedizin 2001; 13: 52-9.
13. Hopstaken RM, et al. Prim Care Resp J 2009;18:in press.
14. Ubenauf KM, et al. Ped Inf Dis J 2007;26:159-62.
15. Behrendt D, et al. Arch Dis Child Fetal Neonatal Ed 2004;89:F551-4.
16. Pavcnik-Arnol M, et al. Int Care Med 2004;30:1454-60.